Browse 24839 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
August 29th, 2023 |
USAID Ghana Health Program (GHP) Annual Program Statement (APS) |
West Africa USAID Ghana |
November 21st, 2022 |
Environmental influences on Child Health Outcomes (ECHO) Data Analysis Center (U24) Clinical Trial Not Allowed |
National Institutes of Health |
November 21st, 2022 |
Environmental influences on Child Health Outcomes (ECHO) Coordinating Center (U2C) (Clinical Trial Not Allowed) |
National Institutes of Health |
November 21st, 2022 |
Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. Clinical Trial Not Allowed (UG3/UH3) |
National Institutes of Health |
November 29th, 2022 |
Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) |
National Institutes of Health |
November 21st, 2022 |
Environmental influences on Child Health Outcomes (ECHO) Laboratory Core (U24) Clinical Trial Not Allowed |
National Institutes of Health |
December 7th, 2022 |
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Basic Experimental Studies with Humans Required) |
National Institutes of Health |
December 7th, 2022 |
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Basic Experimental Studies with Humans Required) |
National Institutes of Health |
December 7th, 2022 |
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
December 7th, 2022 |
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 4th, 2022 |
Support to Zimbabwe's multi-sectoral HIV response |
Zimbabwe USAID Harare |
October 17th, 2023 |
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 10th, 2022 |
Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
June 20th, 2025 |
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 9th, 2023 |
Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors |
Centers for Disease Control and Prevention ERA |
October 13th, 2022 |
Project AWARE (Advancing Wellness and Resiliency in Education) |
Substance Abuse and Mental Health Services Adminis |
October 17th, 2024 |
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
October 17th, 2024 |
NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 1st, 2025 |
Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) |
National Institutes of Health |
June 30th, 2023 |
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
|
November 30th, 2022 |
Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed) |
National Institutes of Health |
October 27th, 2022 |
Limited Competition for the Continuation of the Drug Induced Liver Injury Network Data Coordinating Center (DILIN) (U01 - Clinical Trial Not Allowed) |
National Institutes of Health |
October 26th, 2022 |
Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network Scientific and Data Research Center (APOLLO SDRC) (Collaborative U01 - Clinical Trial Not Allowed) |
National Institutes of Health |
May 25th, 2025 |
NICHD Research Education Programs (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
October 28th, 2022 |
Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
June 30th, 2023 |
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
October 27th, 2022 |
Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01 - Clinical Trial Optional) |
National Institutes of Health |
October 26th, 2022 |
Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed) |
National Institutes of Health |
June 17th, 2025 |
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) |
National Institutes of Health |
November 10th, 2022 |
REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
March 29th, 2023 |
Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 13th, 2023 |
Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 29th, 2023 |
Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
September 30th, 2022 |
Community Led Monitoring -Routine Data Collection and Provider feedback at PEPFAR supported sites |
US Mission to Kenya |
December 1st, 2022 |
MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
November 18th, 2022 |
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) |
National Institutes of Health |
November 19th, 2024 |
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 19th, 2022 |
The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) |
National Institutes of Health |
October 31st, 2026 |
AHRQ Conference Grant Programs (R13) |
Agency for Health Care Research and Quality |
November 2nd, 2022 |
Laboratory of Developmental Biology (R24 Clinical Trial Not Allowed) |
National Institutes of Health |